托烷司琼预防甲状腺癌术后不良反应的临床观察

Clinical observation of tropisetron in preventing postoperative adverse reactions of thyroid cancer

目的探讨托烷司琼预防甲状腺癌术后头痛及恶心呕吐等不良反应的临床效果。方法选择在2014年7月至2016年1月期间就诊的甲状腺癌手术患者90例,按照随机数字表法分为观察组及对照组,各45例。观察组采用托烷司琼预防头痛及恶心呕吐,对照组仅注射生理盐水,对比2组患者的头痛以及恶心呕吐的发生率。结果 2组患者的术前和术中情况差异无统计学意义(P> 0. 05);术后6、12h观察组头痛发生率分别为26. 7%、17. 8%,低于对照组的55. 6%、37. 8%,差异具有统计学意义(P <0. 05);术后6、12 h观察组恶心呕吐发生率分别为22. 2%、8. 9%,低于对照组的46. 7%、20. 0%,差异也具有统计学意义(P <0. 05)。结论甲状腺癌术后给予托烷司琼可以显著改善患者的头痛和恶心呕吐的发生状况,增加患者的舒适度。

AIM To evaluate the clinical efficacy of tropisetron in preventing postoperative adverse reactionssuch as headache,nausea and vomiting of thyroid carcinoma. METHODS Ninety patients with thyroid carci-noma treated from July 2014 to January 2016 were selected and divided into observation group and controlgroup according to random number table. In the observation group,tropisetron was used to prevent vomiting.In the control group,only saline was injected. The incidence of headache,nausea and vomiting between the 2groups was compared. RESULTS There was no significant difference between the 2 groups before and dur-ing operation ( P > 0. 05) . The incidence of headache in the observation group was 26. 7% and 17. 8% at 6hand 12h after operation,which was significantly lower than that of the control group ( 55. 6% and 37. 8% ,P <0. 05) . The incidence of nausea and vomiting in the observation group was 22. 2% and 8. 9%,significantlylower than that in the control group at 6 h and 12 h after operation,and the difference was statistically significant( P <0. 05) . CONCLUSION Tropisetron can significantly improve headache,nausea and vomiting in patientswith the occurrence of increased comfort.